For authorities, industry and science | in English
The Programme for the Cannabis Conference 2025
The development and marketing authorisation of cannabis-based medicinal products is associated with a whole range of challenges. However, they also offer opportunities for the future, since marketing them as magistral formulations based on patient-specific individual prescriptions as off-label use can only be of a temporary nature. In the future, authorised medicinal products will certainly be prescribed not only for the authorised indication but also for no-label use. Our programme will show you the way forward.
Get to know the success factors in development projects with herbal active ingredients, expand your knowledge of risks and how to counter them, and last but not least, use the event for networking and professional exchange.
Please note: The presentations at this conference will be held in English.